The Globe and Mail reports in its Tuesday, June 27, edition that Canaccord Genuity analyst Matthew Lee rates Supremex "buy" in new coverage. The Globe's David Leeder writes in the Eye On Equities column that Mr. Li set a share target of $8.50. Analysts on average target the shares at $9.91. While Mr. Lee believes 2023 could bring "some softness related to customer inventory levels and acquisition integration," he sees the investing thesis for the envelope manufacture as "compelling," pointing to its "substantial cash flow generation, organic growth opportunity in packaging, and M&A track record." He calls Supremex's valuation "attractive" given its shift toward packaging. Mr. Li says in a note: "We believe [Supremex] offers investors a solid combination of growth and cash flow buttressed by its prudent M&A strategy. The envelope segment provides traditional mailing envelopes to large corporate clients primarily focused on billing and direct advertising. The packaging segment centres on specialized containers built for consumer products. In our view, the combination of Supremex's two businesses allow the firm to generate substantial cash flows, which can then be reinvested into areas of secular growth."